UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of antiangiogenesis therapy: Bevacizumab and beyond

Clinical & translational oncology, 2009-06, Vol.11 (6), p.349-355

Cortés-Funes, Hernán

2009

Volltextzugriff (PDF)

The Role of RANK‐Ligand Inhibition in Cancer: The Story of Denosumab

The oncologist (Dayton, Ohio), 2011-02, Vol.16 (2), p.136-145

2011

Volltextzugriff (PDF)

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

Cancer and metastasis reviews, 2010-12, Vol.29 (4), p.751-759

2010

Volltextzugriff (PDF)

Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer

Tumor biology, 2015-02, Vol.36 (2), p.1199-1206

2015

Volltextzugriff (PDF)

Prognostic value of KIT expression in small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2007-06, Vol.56 (3), p.405-413

2007

Volltextzugriff (PDF)

DNA-Repair Gene Polymorphisms Predict Favorable Clinical Outcome Among Patients With Advanced Squamous Cell Carcinoma of the Head and Neck Treated With Cisplatin-Based Induction Chemotherapy

Journal of clinical oncology, 2006-09, Vol.24 (26), p.4333-4339

2006

Volltextzugriff (PDF)

Guidelines for the management of breakthrough pain in patients with cancer

Journal of the National Comprehensive Cancer Network, 2013-03, Vol.11 Suppl 1 (suppl 1), p.S29-S-36

2013

Volltextzugriff (PDF)

A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial

Breast (Edinburgh), 2014-10, Vol.23 (5), p.656-662

2014

Volltextzugriff (PDF)

Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8636-8645

2005

Volltextzugriff (PDF)

DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification

Carcinogenesis (New York), 2013-05, Vol.34 (5), p.1031-1038

2013

Volltextzugriff (PDF)

Effectiveness of oxaliplatin desensitization protocols

Clinical & translational oncology, 2013-03, Vol.15 (3), p.219-225

2013

Volltextzugriff (PDF)

Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin

Molecular cancer, 2017-02, Vol.16 (1), p.45, Article 45

2017

Volltextzugriff (PDF)

Review of a promising new agent—pemetrexed disodium

Cancer, 2003-04, Vol.97 (S8), p.2056-2063

2003

Volltextzugriff (PDF)

Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII

Journal of clinical oncology, 2000-04, Vol.18 (7), p.1412-1422

2000

Volltextzugriff (PDF)

Phase I-II Study of Gemcitabine and Fluorouracil as a Continuous Infusion in Patients With Pancreatic Cancer

Journal of clinical oncology, 1999-02, Vol.17 (2), p.585-592

1999

Volltextzugriff (PDF)

Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Cancer, 2006-01, Vol.106 (1), p.106-111

2006

Volltextzugriff (PDF)

Implication of miRNA in the diagnosis and treatment of breast cancer

Expert review of anticancer therapy, 2011-08, Vol.11 (8), p.1265-1275

2011

Volltextzugriff (PDF)

The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer

Breast (Edinburgh), 2014-06, Vol.23 (3), p.201-208

2014

Volltextzugriff (PDF)

Behaviour of breast cancer molecular subtypes through tumour progression

Clinical & translational oncology, 2012-06, Vol.14 (6), p.481-485

2012

Volltextzugriff (PDF)

Risk factors associated with Clostridium difficile infection in adult oncology patients

Supportive care in cancer, 2015-06, Vol.23 (6), p.1569-1577

2015

Volltextzugriff (PDF)

Clinical experience with plerixafor as a mobilization regimen for autologous peripheral blood stem cell transplantation in patients with refractory germ cell tumors

Molecular and clinical oncology, 2014-11, Vol.2 (6), p.923-926

2014

Volltextzugriff (PDF)

Role of anthracyclines in the era of targeted therapy

Cardiovascular toxicology, 2007-06, Vol.7 (2), p.56-60

2007

Volltextzugriff (PDF)

Biological markers of cisplatin resistance in advanced testicular germ cell tumours

Clinical & translational oncology, 2012-06, Vol.14 (6), p.452-457

2012

Volltextzugriff (PDF)

1 – 25 von 148

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(142)

Publikationsform

Artikel
(148)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(97)
Science & Technology
(97)
Humans
(95)
Oncology
(90)
Female
(74)
Middle Aged
(59)
Adult
(51)
Aged
(50)
Biological And Medical Sciences
(47)
Male
(47)
Medical Sciences
(47)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(35)
Chemotherapy
(27)
Pharmacology. Drug Treatments
(24)
Tumors
(24)
Breast Neoplasms - Pathology
(23)
Prognosis
(23)
Breast Neoplasms - Drug Therapy
(21)
Treatment Outcome
(21)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of antiangiogenesis therapy: Bevacizumab and beyond

The Role of RANK‐Ligand Inhibition in Cancer: The Story of Denosumab

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer

Prognostic value of KIT expression in small cell lung cancer

DNA-Repair Gene Polymorphisms Predict Favorable Clinical Outcome Among Patients With Advanced Squamous Cell Carcinoma of the Head and Neck Treated With Cisplatin-Based Induction Chemotherapy

Guidelines for the management of breakthrough pain in patients with cancer

A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial

Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer

DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification

Effectiveness of oxaliplatin desensitization protocols

Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin

Review of a promising new agent—pemetrexed disodium

Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study

Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII

Phase I-II Study of Gemcitabine and Fluorouracil as a Continuous Infusion in Patients With Pancreatic Cancer

Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Implication of miRNA in the diagnosis and treatment of breast cancer

The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer

Behaviour of breast cancer molecular subtypes through tumour progression

Phase I Pharmacokinetic/Pharmacodynamic Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Combination with Irinotecan, 5-Fluorouracil, and Leucovorin (FOLFIRI) in First-Line Treatment of Patients with Metastatic Colorectal Cancer

Risk factors associated with Clostridium difficile infection in adult oncology patients

Clinical experience with plerixafor as a mobilization regimen for autologous peripheral blood stem cell transplantation in patients with refractory germ cell tumors

Role of anthracyclines in the era of targeted therapy

Biological markers of cisplatin resistance in advanced testicular germ cell tumours

Suchergebnisse filtern